This Tesla Analyst Must Be On ‘Hallucinogenic Drugs,’ Says Value Investor In Response To Morgan Stanley’s Value Proposition
As Tesla Inc (NASDAQ: TSLA) shares continued to slip toward Morgan Stanley's bear case, analyst Adam Jonas started to wonder if Tesla was leaning into value territory.